United States Biotechnology & Medical Research

PharmaCyte Biotech Inc (PMCB)

Track

PharmaCyte Biotech Inc. saw significant insider buying activity in early January 2026. CEO Joshua Silverman and Jonathan Schechter executed multiple purchase transactions between January 5 and January 7, 2026, acquiring a combined total of 160,000 shares. As these transactions occurred more than three months ago, there is no recent insider trading activity to report.
Ticker: PMCB Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for PharmaCyte Biotech Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 7 Jan 2026
Value US$4,689,102.33 | Price 337.82 | Shares 69,997 (+10.8%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-01-07 2026-01-07 B Purchase
2.4
Silverman Joshua

CEO and President

Executive Director
69,997 +10.8%
337.82
US$4,689,102 		69,997 +10.8% 337.82 US$4,689,102
2026-01-07 2026-01-07 B Purchase
1.6
SCHECHTER JONATHAN
Non-Executive Director
56,962 +25.1%
238.73
US$1,035,932 		56,962 +25.1% 238.73 US$1,035,932
2026-01-07 2026-01-06 B Purchase
2.4
Silverman Joshua

CEO and President

Executive Director
75,808 -37.8%
434.25
US$1,472,386 		75,808 -37.8% 434.25 US$1,472,386
2026-01-07 2026-01-06 B Purchase
1.6
SCHECHTER JONATHAN
Non-Executive Director
20,000 +13.1%
0.79
US$15,808 		20,000 +13.1% 0.79 US$15,808
2026-01-07 2026-01-05 B Purchase
2.4
Silverman Joshua

CEO and President

Executive Director
30,000 +9.5%
0.78
US$23,493 		30,000 +9.5% 0.78 US$23,493
2026-01-07 2026-01-05 B Purchase
1.6
SCHECHTER JONATHAN
Non-Executive Director
20,000 +15.1%
0.78
US$15,552 		20,000 +15.1% 0.78 US$15,552
Explore more

More insider trading research around PharmaCyte Biotech Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America